Tim-3 suppression combined with TLR3 activation enhances antiviral immune response in patients with chronic HCV infection

Conclusions
Tim-3 blockade in combination with TLR activation induces the expression of antiviral molecules without a significant increase in TNF-α or SOCS1.

Source: Journal of International Medical Research - July 21, 2016 Category: Research Authors: Nan, Y.-m., Su, S.-s., Niu, X.-m., Zhao, S.-x., Zhang, Y.-g., Wang, R.-q., Kong, L.-b., He, H., Zheng, H.-w., Sun, D.-x. Tags: Research Reports Source Type: research